This content is machine translated Non-small cell lung cancer CheckMate 057 with promising results Patients with advanced non-squamous type non-small cell lung cancer (NSCLC) benefit from nivolumab after failed platinum-containing chemotherapy. This is the conclusion of the CheckMate 057 study. The tested substance was…
View Post 3 min This content is machine translated Venous thromboembolism Do patients with pancreatic cancer benefit from prophylaxis? Advanced pancreatic cancer is associated with a significantly increased risk of venous thromboembolism: within one year, approximately one fifth of patients suffer such a complication – with devastating consequences. What…
View Post 2 min This content is machine translated Breast cancer in the family Is the prognosis worsening? Family history is not an independent risk factor for worse outcome in young women with breast cancer. This is the result of a British study in which the data of…
View Post 3 min This content is machine translated Transcatheter Aortic Valve Implantation (TAVI) 1-year results of the SAPIEN 3 study At EuroPCR, the Congress of Interventional Medicine, held in Paris in May 2015, the latest results of various studies on TAVI (transcatheter aortic valve implantation) were presented, among other topics.…
View Post 2 min This content is machine translated Cancer Prevention Do statins protect against liver cancer? Several studies have shown that statin therapy reduces the risk of liver cancer. However, most of these papers come from countries with high incidence of liver cancer (Asian region). Now…
View Post 3 min This content is machine translated Prostate Cancer What is the effect of enzalutamide before chemotherapy? Enzalutamide (Xtandi®) prolongs survival in men whose metastatic castration-resistant prostate cancer is progressive after chemotherapy. But is the oral androgen receptor pathway inhibitor also effective in patients who have already…
View Post 7 min This content is machine translated 17th Basel Oncology Talks on Malignant Melanoma Targeted and immunological therapies – what is the current status? This time, a comprehensive overview of the current state of research in the field of targeted and immunological therapeutic approaches for metastatic melanoma was given at the Oncology Talks held…
View Post 2 min This content is machine translated Concomitant symptoms of cancer therapy What is the risk of xerosis? Many targeted cancer treatments promote the development of dry skin, called xeroderma or xerosis cutis. A meta-analysis now shows how high the incidence and relative risk actually are.
View Post 2 min This content is machine translated Lung cancer Living longer thanks to cancer? A current forecast [1] for the year 2015, which is based on statistics from the WHO and data from individual European countries, indicates that theThe picture regarding lung cancer is…
View Post 4 min This content is machine translated EHA Congress in Vienna Multiple Myeloma News From June 11 to 14, 2015, the congress of the “European Hematology Association” took place in Vienna. Among many other news, there were of course also updates on multiple myeloma.…
View Post 2 min This content is machine translated New study on combined immunotherapy in melanoma Combination of nivolumab and ipilimumab is superior to monotherapy Melanomas account for less than 5% of all skin cancers, but they claim the most lives. How to optimize the therapy? The CheckMate-069 trial, published in the New England Journal…
